A thorny ALS debate at the FDA, and the promise of artificial wombs
Can the FDA be too flexible? How do you test a mechanical womb? And who decides what's good enough for patients in need? Find out on the new episode of…
Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.
What's Your Reaction?
